OpenAlex
PricingAboutJobs
Log inGet started
Work

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

HTML

Year: 2010
Type: article
Source: Oncogene
DOI: 10.1038/onc.2009.510
Authors: L Santo, S Vallet, T Hideshima, D Cirstea, H Ikeda, S Pozzi, K Patel, Y Okawa, G Gorgun, G Perrone, E Calabrese, M Yule, M Squires, M Ladetto, M Boccadoro, P G Richardson, N C Munshi, K C Anderson, N Raje
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, University of Turin
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: AT7519, multiple myeloma, cyclin-dependent kinase inhibitors, apoptosis, RNA polymerase II phosphorylation, CDK9, CDK7, RNA synthesis inhibition, alpha-amanitin, cell cycle dysregulation, anticancer activity
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Awards: Host-tumor cell interaction in myeloma: therapeutic applications, SPORE in Multiple Myeloma
OpenAlex ID: W2080278485
FWCI: 5.681
Cites: 47
Cited by: 152
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security